论文信息 - Transient neutropenia may be a risk of treating preterm neonates with high doses of recombinant erythropoietin - 字舞流文

Transient neutropenia may be a risk of treating preterm neonates with high doses of recombinant erythropoietin

G. Latini | E. Rosati

[1] M. Levene,et al. Blood transfusions and human recombinant erythropoietin in premature newborn infants. , 1996, Archives of disease in childhood. Fetal and neonatal edition.

[2] S. Lamberts,et al. Clinical aspects of glucocorticoid sensitivity , 1996, Steroids.

[3] R. Ehrenkranz,et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. , 1995, Pediatrics.

[4] G. Duc,et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants , 1994 .

[5] P. Lanzkowsky,et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. , 1992, The Journal of pediatrics.

[6] G. Walco,et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. , 1992, The Journal of pediatrics.

[7] R. Christensen,et al. Erythropoietin affects the maturation pattern of fetal G‐CSF‐responsive progenitors , 1992, American journal of hematology.

[8] K. Schibler,et al. Administration of erythropoietin to newborn rats results in diminished neutrophil production. , 1991, Blood.

[9] S. Werlin,et al. Severe colitis in children and adolescents: diagnosis. Course, and treatment. , 1977, Gastroenterology.